Late last year, Japan took a big step towards cannabis reform after passing a bill to amend...
There are 26 contracts signed by various hospital entities to purchase Cannabidiol (CBD), since October 2021, with purchases of the drug Epidyolex soaring in Portugal in...
Roger Nakazawa, CEO of Asabis, is one of the main organizers of the CBD Journey & CannaCon 2023 exhibition and conference, taking place today and tomorrow in...
Japan's largest CBD and hemp exhibition and conference takes place this week, November 2nd and 3rd, at Shibuya Stream Hall in Tokyo...
The Israeli Government has announced the implementation of measures by the end of 2023 that will allow more comprehensive and simplified access to medical cannabis. The process of...
Infarmed – National Authority for Medicines and Health Products IP today ordered the withdrawal of Cannabiron CBD and Good Cannabis creams from the market, as they contain...
PAX, a renowned global cannabis brand, is pleased to unveil its latest addition, My PAX®, an exclusive program that brings...
The Ministry of Health of the Czech Republic has announced its decision to regulate, rather than ban, the production of synthetic compounds derived from CBD from...
Cannabis is often associated with the pleasant “high” that it can provide, most of the time with a feeling of relaxation, a good mood or a desire to laugh at...
In a revolutionary move, Meta, the parent company that controls Facebook, along with its sister platforms Instagram and Thread (not yet available in EU countries...